Calla Lily Clinical Care has dosed the first patients in its Freedom clinical trial, a nihr‑funded study evaluating the ...

Palisade Bio has released further phase 1a/b analyses of its investigational PDE4 inhibitor prodrug PALI‑2108, adding new ...

The conversation about AI in pharmacovigilance has typically focused on automating individual steps in the case processing ...

Mid-size pharmaceutical companies operate in one of the most complex environments in healthcare. They pursue innovative ...

Boehringer Ingelheim has reported positive topline results from the phase III SYNCHRONIZE‑1 trial, showing that its ...

The study, sponsored jointly by MimiVax and Roswell Park, is led by principal investigator Dr Jasmeet Kaur.

There is a growing disconnect between what the industry is offering in terms of digital customer experience and what ...

Omron has appointed Virendra Shelar as Executive Officer, President and CEO of Omron Europe. He will be based at the ...

David Apelian, CEO of Theolytics, said: “We are proud to announce the dosing of the first patient in this important study.” ...

UCB has entered a new multi‑project strategic alliance with Cancer Research UK and its innovation arm, Cancer Research ...

BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...

For much of its history, the answer, while never perfectly clear, followed a recognisable chain of command. Ministers set ...